Literature DB >> 18712716

Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.

Baisakhi Saha1, Pavinder Kaur, Denice Tsao-Wei, Wesley Y Naritoku, Susan Groshen, Ram H Datar, Lawrence W Jones, S Ashraf Imam.   

Abstract

BACKGROUND: The concurrent determination of methylation status of E-cadherin gene and E-cadherin protein expression remains scant in metastatic prostate cancer cells in bone, the most prevalent site for metastatic growth. Therefore, the study was undertaken to ascertain the methylation status of E-cadherin gene, a most frequent and known epigenetic mechanism of its regulation, and the protein expression in prostate tissue biopsy specimen.
METHODS: The methylation of E-cadherin gene was determined by methylation specific-PCR and the protein expression by immunohistochemical method in the consecutive sections of each prostate tissue biopsy specimen.
RESULTS: The unmethylated E-cadherin gene and homogeneous E-cadherin protein expression was significantly associated with BPH as compared to the primary prostate carcinoma (Fisher's Exact P < 0.001). A significant association was observed between the concurrent methylated gene and markedly reduced expression of the protein in the primary prostate cancer cells as compared to the BPH cells, suggesting methylation-dependent regulation of the gene expression in these cases. In contrast to the primary cancer, a highly significant increase in the frequency of metastatic prostate cancer cells in bone exhibited the concurrent expression of unmethylated gene and homogeneous protein (Fisher's Exact P < 0.001).
CONCLUSIONS: The study clearly demonstrated a significant association of the concurrent expression of unmethylated E-cadherin gene and E-cadherin protein with metastatic prostate cancer cells in bone, and that its expression may have a role in the intercellular adhesion in the formation of metastatic lesions in bone. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18712716     DOI: 10.1002/pros.20836

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  13 in total

Review 1.  The role of epithelial plasticity in prostate cancer dissemination and treatment resistance.

Authors:  Rhonda L Bitting; Daneen Schaeffer; Jason A Somarelli; Mariano A Garcia-Blanco; Andrew J Armstrong
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

2.  Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.

Authors:  Seema Sethi; Jill Macoska; Wei Chen; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2010-10-23       Impact factor: 4.060

Review 3.  Prostate tumor cell plasticity: a consequence of the microenvironment.

Authors:  Clayton Yates
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 4.  Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

Authors:  Jones T Nauseef; Michael D Henry
Journal:  Nat Rev Urol       Date:  2011-06-21       Impact factor: 14.432

Review 5.  Role of epithelial mesenchymal transition in prostate tumorigenesis.

Authors:  Mohammad Imran Khan; Abid Hamid; Vaqar Mustafa Adhami; Rahul K Lall; Hasan Mukhtar
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  DNA methylation in promoter region as biomarkers in prostate cancer.

Authors:  Mihi Yang; Jong Y Park
Journal:  Methods Mol Biol       Date:  2012

7.  Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.

Authors:  Larry Fliegel
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

8.  CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer.

Authors:  Qi-Ming Yu; Xin-Bao Wang; Jun Luo; Shi Wang; Xian-Hua Fang; Jiang-Liu Yu; Zhi-Qiang Ling
Journal:  J Surg Oncol       Date:  2012-04-18       Impact factor: 3.454

Review 9.  Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples.

Authors:  Hafiz Ahmed
Journal:  Biomark Cancer       Date:  2010-02-18

10.  Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells.

Authors:  Sajni Josson; Starlette Sharp; Shian-Ying Sung; Peter A S Johnstone; Ritu Aneja; Ruoxiang Wang; Murali Gururajan; Timothy Turner; Leland W K Chung; Clayton Yates
Journal:  J Oncol       Date:  2010-07-29       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.